Watch Ticker

Nuvalent, Inc. Class A Common Stock

Go to Nuvalent, Inc. Class A Common Stock Website

$77.23

-1.39 (-1.77%)

Live

Previous Close

$77.23

Day Range

$75.06 - $78.12

Previous Day Range

$77.27 - $80.15

Market Cap

$5.6 billion USD

Day Vol.

409684

Previous Day Vol.

499902

Currency

USD

Primary Exchange

Nasdaq

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity

Nuvalent presented positive data from its Phase 1/2 trials for zidesamtinib and NVL-655 at the ESMO Congress 2024. The company plans to initiate a Phase 3 trial for NVL-655 in the first half of 2025 and expects pivotal data from both trials in 2025. Nuvalent also announced a $350 million public offering.

Related tickers: NUVL.

Read Full Article

Zacks Equity Research - Why Earnings Season Could Be Great for Nuvalent (NUVL)

Nuvalent (NUVL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Related tickers: NUVL.

Read Full Article

Trending Tickers

Please sign in to view